This asset swap enabled both companies to build on their existing strengths while creating value for our assets. GSK was an official supplier to London Olympic and Paralympic Games, providing official laboratory services for anti-doping measures.
Since then, new priorities have been introduced to help us deliver our purpose to help people do more, feel better and live longer. Read more about us here. In this period, our legacy companies expanded globally, developing and selling new products worldwide.
An era of landmark scientific breakthroughs, building brand portfolios and product consolidation. The company has also continued to work with the WHO in its fight to combat lymphatic filariasis, and even donated the first million of its albendazole tablets.
On th July , ten million people in Sri Lanka received these free doses. By the end of , GSK had donated million treatments, and found itself as the recipient of the New Business Award. GSK has also been on hand when natural disasters have struck, donating medicines and vaccines following the Tsunami disaster of December , after the damage caused in the USA by Hurricane Katrina in and also following the Haiti earthquake in Over the years, GSK has continued to research and develop new treatments and acquire new products.
Advances in technology will also continue to pressure GSK, and other pharmaceutical companies, into finding more sufficient treatments and vaccines.
We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare. You are currently visiting our global website. Our history Beginning in with the opening of an apothecary shop in London, our story has always focused on innovation.
Explore our history timeline. In March, the two pharma majors had entered into an alliance for co-marketing an advanced dosage form of the antibiotic, Cephalexin, in the country. This holding is 51 per cent of the total paid-up share capital of the company. They now form a new company named GlaxoSmithKline plc. The new company is well-placed to respond to the healthcare challenges of the twenty first century with market leadership in major therapeutic categories.
It acquired two groups. The Burroughs Wellcome India Ltd. Subsequently, it acquired the Biddle Sawyer Group , the approval for which was received. In an agreement reached between the two partners, Max GB will supply 7 ADCA to the company, who will convert it into bulk Cephalexin for the joint venture company at one of the company's manufacturing facility, which will be made available for this purpose.
0コメント